Springer and the European Association for Predictive, Preventive and Personalised Medicine have founded, as the Association's official publication, the EPMA Journal. Creating a reliable scientific platform for the optimal combination of conventional medicine with new advances in biomedicine and laboratory medicine, the EPMA Journal will highlight worldwide progress in the emerging discipline of predictive, preventive and personalised medicine.
The EPMA Journal promotes a new philosophy in patient treatment - the change from curative medicine to predictive and preventive medicine. Published quarterly, it will provide an overview of three essential components which form the basis of medicine of the future: advanced predictive diagnostic technologies, targeted preventive measures, and personalised approaches to treatment. The journal will address these issues in the form of editorial overviews, review articles and annotated papers.
Editor-in-chief Dr. Olga Golubnitschaja of the Friedrich Wilhelms University of Bonn, Germany, said, "People across all walks of life are increasingly demanding to be better informed of changes in their health as they progress through life. One of the central issues to be discussed in the journal is the screening for predisposition of healthy individuals to potential pathologies later in life. We intend the EPMA Journal to stimulate discussion on many issues related to the future practice of predictive and personalized medicine."
Melania Ruiz, Publishing Editor, Cancer Research at Springer, said, "The EPMA Journal will explore new philosophies in medicine and track novel trends in healthcare and biomedical education. Springer is delighted to collaborate with the European Association for Predictive, Preventive and Personalised Medicine on this unique new journal."
The EPMA Journal will be available in print and on Springer's online platform www.springerlink.com starting in March 2010. All articles will be published online via Online First™ before they appear in print, thereby enabling research results to be disseminated quickly to the scientific community. In addition, all authors, via the Springer Open Choice™ program, have the option of publishing their articles using the open access publishing model.
Springer (www.springer.com) is a leading global scientific publisher of books and journals, delivering quality content through innovative information products and services. It publishes close to 500 academic and professional society journals. Springer is part of the publishing group Springer Science+Business Media. In the science, technology and medicine (STM) sector, the group publishes around 2,000 journals and more than 6,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and more than 5,000 employees.
The EPMA Journal
International Reviews in Predictive, Preventive and Personalized Medicine
ISSN: 1878-5077 (print version), ISSN: 1878-5085 (electronic version)